Kohl's Corp (KSS.US) stock slid over 21.0% on Friday after the department store chain called off its sale to Vitamin Shoppe-owner Franchise Group, as deteriorating retail and financial environment presented significant obstacles to concluding a takeover deal worth approximately $8 billion.
- Yesterday CNBC was the first to report that Kohl's was terminating talks to sell its business, which began at the beginning of June, after speculation emerged that the Franchise Group was trying to lower its bid for Kohl's by $10, to $50 a share, amid the broader market sell-off.
- Kohl's is planning to launch an "accelerated share repurchase program" in order to erase some of the recent losses and will provide more details regarding his next steps in the current rocky retail environment when it publishes second quarter earnings on August 18.
- Company also lowered its current-quarter financial guidance due to weaker consumer spending. Kohl now expects that sales will fall to high-single digits, compared with a prior forecast of down low-single digits relative to last year.
Kohl's Corp (KSS.US) stock launched today’s session with a massive bearish price gap. If sellers will manage to uphold current momentum then downward move may deepen towards the key support zone around $22.10 which is marked with lower limit of the 1:1 structure and 78.6% Fibonacci retracement of the downward wave launched in March 2020. In order to make the outlook more bullish, buyers would have push the price back above 61.8% retracement in the $30.75 area. Source: xStation5
Start investing today or test a free demo
Create account Try a demo Download mobile app Download mobile appThe content of this report has been created by XTB S.A., with its registered office in Warsaw, at Prosta 67, 00-838 Warsaw, Poland, (KRS number 0000217580) and supervised by Polish Supervision Authority ( No. DDM-M-4021-57-1/2005). This material is a marketing communication within the meaning of Art. 24 (3) of Directive 2014/65/EU of the European Parliament and of the Council of 15 May 2014 on markets in financial instruments and amending Directive 2002/92/EC and Directive 2011/61/EU (MiFID II). Marketing communication is not an investment recommendation or information recommending or suggesting an investment strategy within the meaning of Regulation (EU) No 596/2014 of the European Parliament and of the Council of 16 April 2014 on market abuse (market abuse regulation) and repealing Directive 2003/6/EC of the European Parliament and of the Council and Commission Directives 2003/124/EC, 2003/125/EC and 2004/72/EC and Commission Delegated Regulation (EU) 2016/958 of 9 March 2016 supplementing Regulation (EU) No 596/2014 of the European Parliament and of the Council with regard to regulatory technical standards for the technical arrangements for objective presentation of investment recommendations or other information recommending or suggesting an investment strategy and for disclosure of particular interests or indications of conflicts of interest or any other advice, including in the area of investment advisory, within the meaning of the Trading in Financial Instruments Act of 29 July 2005 (i.e. Journal of Laws 2019, item 875, as amended). The marketing communication is prepared with the highest diligence, objectivity, presents the facts known to the author on the date of preparation and is devoid of any evaluation elements. The marketing communication is prepared without considering the client’s needs, his individual financial situation and does not present any investment strategy in any way. The marketing communication does not constitute an offer of sale, offering, subscription, invitation to purchase, advertisement or promotion of any financial instruments. XTB S.A. is not liable for any client’s actions or omissions, in particular for the acquisition or disposal of financial instruments, undertaken on the basis of the information contained in this marketing communication. In the event that the marketing communication contains any information about any results regarding the financial instruments indicated therein, these do not constitute any guarantee or forecast regarding the future results.
